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Abstract 
Chromatin immunoprecipitation and sequencing (ChIP-seq) provides a static snap-
shot of DNA-associated proteins which fails to reflect the dynamics of the DNA-bound 
proteome. Now, Catic and co-workers combine ubiquitin ChIP-seq and proteasome 
inhibitors to map sites of DNA-associated protein degradation on a genome-wide 
scale. They identify an ubiquitin ligase which targets a transcriptional repressor for 
destruction by the proteasome, thus activating transcription of specific genes. These 
findings reveal that the ubiquitin proteasome system actively regulates transcription.  
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Understanding mechanisms of gene expression control is perhaps the biggest 
challenge of the post genomic era. Protein abundance is regulated at all levels from 
transcription to protein degradation1. Current research mainly focuses on 
transcriptional control by activators and repressors that bind to specific DNA 
sequences. These interactions can now be studied on a genome-wide scale. 
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) generates 
genomic maps of interactions between proteins and their posttranslational 
modifications with DNA.  
 
It is known for some time that the ubiquitin proteasome system (UPS) also plays a 
role in transcription2. In fact, one of the subunits of the proteasome was originally 
identified on the basis of mutations that suppressed defects in the yeast transcription 
activator Gal43. A growing body of evidence suggests a direct mechanistic link 
between the UPS and transcription. For example, activity of the UPS is required for 
efficient transcription of certain genes4. However, a comprehensive picture of DNA-
associated protein turnover has until now been lacking. 
 
Now, the lab of David Scadden use ChIP-seq to investigate DNA-associated protein 
turnover on a global scale5. They transfected human and mouse cells with tagged 
ubiquitin which they could pull down to sequence the associated DNA. However, also 
histones are frequently mono-ubiquitinated, and this modification does not induce 
degradation. So how is it then possible to distinguish regions of degradative 
ubiquitination from other sites of ubiquitination? Catic et al. chose a pragmatic 
approach and deployed the proteasome inhibitor lactacystin: An increase in 
ubiquitination compared to untreated cells then indicates DNA-associated protein 
degradation at the respective genomic location. As an added bonus, lactacystin also 
depletes nuclear mono-ubiquitin which reduces the background6. They found that 
DNA associated protein turnover correlates with actively transcribed genes, as 
previously shown in yeast7. A closer look revealed enrichment in nuclear encoded 
mitochondrial genes, many of which contained binding motifs of the transcriptional 
enhancer CREB in their promoter regions. CREB itself however was not degraded as 
its binding did not change much upon proteasome inhibition. Instead, the authors 
identified the CREB interacting co-repressor NCoR1 as the target of ubiquitination. 
This ubiquitination is mediated by the E3 ligase Siah2 and leads to rapid NCoR1 
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degradation. Consequently, knocking down Siah2 or blocking the proteasome both 
affects mitochondrial function negatively. 
 
The model emerging from these data is straight forward: To activate transcription, a 
ubiquitin ligase (like Siah2 in this study) targets a transcriptional repressor (here 
NCoR1) for degradation, thus derepressing the gene (Fig. 1 A). In this model, 
continuous degradation of the repressor is necessary for efficient transcription. 
Alternatively, it is also conceivable that the UPS could target enhancers and thus 
represses specific genes (Fig. 1 B). Finally, it is known that the UPS can remove 
“spent” transcription activators to allow binding of fresh molecules4. Thus, 
degradation of transcriptional enhancers can also increase transcription (Fig. 1 C).  
 
What are the functional implications? On one hand, targeted degradation of DNA-
associated proteins adds another layer of regulation which may be required to 
achieve complex gene expression patterns. Accordingly, E3 ligases can be regarded 
as a novel class of trans-acting factors involved in transcription regulation. On the 
other hand, high turnover of DNA-binding proteins is also required for rapid changes 
in transcription. In fact, transcriptional regulators and chromatin-modifying enzymes 
tend to be unstable at both the protein and the mRNA level8. To some extent, 
chromatin-associated protein degradation may thus simply reflect the fact that many 
DNA-binding proteins are generally unstable. 
 
As is the case for many pioneering papers, the work by Catic et al. opens up many 
questions. For example, except for NCoR1, it is not known which proteins are 
targeted. Proteomics could help quantifying changes in ubiquitination of individual 
proteins on a global scale6,9. Moreover, the assay developed by the authors is 
indirect and does not prove that proteins are indeed degraded. The use of 
proteasome inhibitors is a particular concern because it is expected to induce 
unwanted side-effects. This could be addressed by using metabolic pulse labeling 
methods which can quantify protein turnover with less interference10. Future studies 
will provide new insights into the role of the UPS in transcriptional regulation.  
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Figure Legend 
 
Fig 1: Possible modes of transcriptional regulation by DNA-associated protein 
degradation. A, Poly-ubiquitination by an E3 ligase (E3) and proteasomal 
degradation of repressors (R) can de-repress genes and promote transcription. B, A 
gene can also be turned off by the elimination of an essential transcription activator. 
C, Degradation of a “used up” activator allows a new functional one to replace it and 
thus increases transcription. 
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